Akebia Therapeutics Inc Corporate Call Transcript
Good day, and thank you for standing by. Welcome to Akebia Therapeutics Corporate Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to turn the conference over to your first speaker today to Mercedes Carrasco, Director of Corporate Communications. Please go ahead.
Thank you, and thank you for attending the Akebia conference call to discuss a recent regulatory update related to vadadustat. Please note that a press release was issued on Wednesday, March 30, detailing the regulatory update, and that release is available on the Investors section of our website. For your convenience, a replay of today's call will be available on our website shortly after we conclude.
Joining me today for today's call is John Butler, Chief Executive Officer; Dave Spellman, Chief Financial Officer; Dell Faulkingham, Chief Commercial Officer; and Dr. Steven Burke, our Head of R&D and Chief Medical
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |